ABBOTT LABORATORIES
10-Q · 2014-11-06T00:00:00Z · 0001104659-14-07776951 tables
Uncategorized (51)
- R10.htmDiscontinued Operations
10301 - Disclosure - Discontinued Operations
- R11.htmSupplemental Financial Information
10401 - Disclosure - Supplemental Financial Information
- R12.htmChanges in Accumulated Other Comprehensive Income (Loss)
10501 - Disclosure - Changes in Accumulated Other Comprehensive Income (Loss)
- R13.htmBusiness Acquisitions
10601 - Disclosure - Business Acquisitions
- R14.htmGoodwill and Intangible Assets
10701 - Disclosure - Goodwill and Intangible Assets
- R15.htmRestructuring Plans
10801 - Disclosure - Restructuring Plans
- R16.htmIncentive Stock Programs
10901 - Disclosure - Incentive Stock Programs
- R17.htmFinancial Instruments, Derivatives and Fair Value Measures
11001 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures
- R18.htmLitigation and Environmental Matters
11101 - Disclosure - Litigation and Environmental Matters
- R19.htmPost-Employment Benefits
11201 - Disclosure - Post-Employment Benefits
- R1.htmDocument and Entity Information
00090 - Document - Document and Entity Information
- R20.htmTaxes on Earnings
11301 - Disclosure - Taxes on Earnings
- R21.htmSegment Information
11401 - Disclosure - Segment Information
- R22.htmDiscontinued Operations (Tables)
30303 - Disclosure - Discontinued Operations (Tables)
- R23.htmSupplemental Financial Information (Tables)
30403 - Disclosure - Supplemental Financial Information (Tables)
- R24.htmChanges in Accumulated Other Comprehensive Income (Loss) (Tables)
30503 - Disclosure - Changes in Accumulated Other Comprehensive Income (Loss) (Tables)
- R25.htmBusiness Acquisitions (Tables)
30603 - Disclosure - Business Acquisitions (Tables)
- R26.htmRestructuring Plans (Tables)
30803 - Disclosure - Restructuring Plans (Tables)
- R27.htmIncentive Stock Programs (Tables)
30903 - Disclosure - Incentive Stock Programs (Tables)
- R28.htmFinancial Instruments, Derivatives and Fair Value Measures (Tables)
31003 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Tables)
- R29.htmPost-Employment Benefits (Tables)
31203 - Disclosure - Post-Employment Benefits (Tables)
- R2.htmCondensed Consolidated Statement of Earnings
00100 - Statement - Condensed Consolidated Statement of Earnings
- R30.htmSegment Information (Tables)
31403 - Disclosure - Segment Information (Tables)
- R31.htmSeparation of AbbVie Inc. (Details)
40201 - Disclosure - Separation of AbbVie Inc. (Details)
- R32.htmDiscontinued Operations (Details)
40301 - Disclosure - Discontinued Operations (Details)
- R33.htmDiscontinued Operations (Details 2)
40302 - Disclosure - Discontinued Operations (Details 2)
- R34.htmSupplemental Financial Information (Details)
40401 - Disclosure - Supplemental Financial Information (Details)
- R35.htmChanges in Accumulated Other Comprehensive Income (Loss) (Details)
40501 - Disclosure - Changes in Accumulated Other Comprehensive Income (Loss) (Details)
- R36.htmBusiness Acquisitions (Details)
40601 - Disclosure - Business Acquisitions (Details)
- R37.htmGoodwill and Intangible Assets (Details)
40701 - Disclosure - Goodwill and Intangible Assets (Details)
- R38.htmGoodwill and Intangible Assets (Details 2)
40702 - Disclosure - Goodwill and Intangible Assets (Details 2)
- R39.htmGoodwill and Intangible Assets (Details 3)
40703 - Disclosure - Goodwill and Intangible Assets (Details 3)
- R3.htmCondensed Consolidated Statement of Comprehensive Income
00200 - Statement - Condensed Consolidated Statement of Comprehensive Income
- R40.htmRestructuring Plans (Details)
40801 - Disclosure - Restructuring Plans (Details)
- R41.htmRestructuring Plans (Details 2)
40802 - Disclosure - Restructuring Plans (Details 2)
- R42.htmIncentive Stock Programs (Details)
40901 - Disclosure - Incentive Stock Programs (Details)
- R43.htmFinancial Instruments, Derivatives and Fair Value Measures (Details)
41001 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details)
- R44.htmFinancial Instruments, Derivatives and Fair Value Measures (Details 2)
41002 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details 2)
- R45.htmFinancial Instruments, Derivatives and Fair Value Measures (Details 3)
41003 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details 3)
- R46.htmFinancial Instruments, Derivatives and Fair Value Measures (Details 4)
41004 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details 4)
- R47.htmLitigation and Environmental Matters (Details)
41101 - Disclosure - Litigation and Environmental Matters (Details)
- R48.htmPost-Employment Benefits (Details)
41201 - Disclosure - Post-Employment Benefits (Details)
- R49.htmTaxes on Earnings (Details)
41301 - Disclosure - Taxes on Earnings (Details)
- R4.htmCondensed Consolidated Statement of Comprehensive Income (Parenthetical)
00205 - Statement - Condensed Consolidated Statement of Comprehensive Income (Parenthetical)
- R50.htmSegment Information (Details)
41401 - Disclosure - Segment Information (Details)
- R51.htmSegment Information (Details 2)
41402 - Disclosure - Segment Information (Details 2)
- R5.htmCondensed Consolidated Balance Sheet
00300 - Statement - Condensed Consolidated Balance Sheet
- R6.htmCondensed Consolidated Balance Sheet (Parenthetical)
00305 - Statement - Condensed Consolidated Balance Sheet (Parenthetical)
- R7.htmCondensed Consolidated Statement of Cash Flows
00400 - Statement - Condensed Consolidated Statement of Cash Flows
- R8.htmBasis of Presentation
10101 - Disclosure - Basis of Presentation
- R9.htmSeparation of AbbVie Inc.
10201 - Disclosure - Separation of AbbVie Inc.